Cytochrome P450 oxidoreductase (POR) is the electron donor for microsomal cytochrome P450 enzymes and other non-P450 enzymes. Targeted deletion of POR expression in mice leads to a variety of embryonic defects, including bone abnormalities. In addition, POR mutations in humans are associated with impaired steroidogenesis and skeletal malformations. Yet, little is known on the mechanisms underlying the skeletal abnormalities secondary to impaired POR activity. In our study, rat chondrocytes transfected with POR-specific short interfering RNAs exhibited decreased cell proliferation and differentiation and induced apoptosis. In addition, the reduced expression of POR in chondrocytes caused decreased intracellular cholesterol content. The addition of cholesterol in the culture medium prevented the POR small interfering RNA (siRNA)-mediated effects on chondrocyte proliferation, differentiation, and apoptosis. Because cholesterol is required for normal activity of the hedgehog proteins, we evaluated the effects of POR siRNAs on the expression of Indian hedgehog (Ihh), an important regulator of chondrogenesis. POR siRNA-transfected chondrocytes exhibited reduced Ihh expression, with such effect being neutralized by cholesterol. Lastly, recombinant human/mouse Ihh prevented the POR siRNA-mediated effects on chondrocyte proliferation, differentiation, and apoptosis. Our findings suggest that the bone malformations associated with defective POR activity are due to reduced cholesterol synthesis and, in turn, reduced Ihh expression in chondrocytes. (Endocrinology 150: 2732-2739, 2009) 
P
450 oxidoreductase (POR) is an 82-kDa, microsomal membrane-associated protein (1, 2) coded by a gene comprising 16 exons (15 coding and one noncoding exons) on chromosome 7q11.2 (3) . POR contains a flavin adenine dinucleotide moiety that accepts a pair of electrons from oxidation of nicotinamide adenine dinucleotide phosphate, and a flavin mononucleotide moiety that accepts the electrons from flavin adenine dinucleotide and transfers them to a cytochrome P450 enzyme as well as a variety of other acceptors (1) . The cytochrome P450 enzymes are grouped in two classes: type I and type II enzymes (1) . Type II P450 enzymes, which use POR as electron donor, are located in the endoplasmic reticulum and include hepatic enzymes involved in drug metabolism and retinoic acid metabolism; enzymes responsible for cholesterol synthesis; and three steroidogenic enzymes critical for the synthesis of glucocorticoids and sex steroids (P450c17), glucocorticoids and mineralcorticoids (P450c21), and estrogens from androgens (P450aro).
Development of the mammalian embryo requires temporally and spatially regulated synthesis and degradation of signaling factors, many of which, such as retinoic acid, sterols, prostaglandins, and steroids (4 -7) , are dependent on the activity of POR. To support an essential role for POR early in embryogenesis, POR transcripts have been detected in two-cell stage of embryonic development (8, 9) . Targeted deletion of POR expression in mice leads to a variety of embryonic defects, including limb abnormalities (10, 11) . POR mutations have been identified in humans with impaired steroidogenesis, ambiguous genitalia, and skeletal abnormalities (12) . The skeletal malformations associated with POR mutations are also observed in a rare congenital disorder called Antley-Bixler syndrome (3, (13) (14) (15) (16) (17) (18) . This syndrome is characterized by craniosynostosis, radioulnar or radiohumeral synostosis, femoral bowing, arachnodactyly, and joint contractures (19) . With respect to the underlying mechanisms of skeletal malformations associated with impaired POR activity, several lines of evidence implicate a role for cholesterol (13) .
Impaired cholesterol biosynthesis appears to play an important role in the development of skeletal abnormalities. Genetic disorders with defective cholesterol biosynthesis are associated with skeletal abnormalities (20) . In addition, we have previously shown that cholesterol synthesized in growth plate chondrocytes, possibly by facilitating the activity of Indian hedgehog (Ihh), plays a key role in the regulation of growth plate chondrogenesis and longitudinal bone growth (21) . Furthermore, two enzymes participating to cholesterol biosynthesis (lanosterol-14␣-demethylase and squalene monooxygenase) require POR as electron donor (22, 23) . Based on this evidence, we hypothesized that normal POR activity in chondrocytes is important for cholesterol synthesis and, in turn, normal bone development and growth. According to this hypothesis, POR mutations in humans lead to skeletal malformations due to impaired cholesterol synthesis in growth plate chondrocytes.
To test our hypothesis, we first evaluated POR mRNA and protein expression in cultured chondrocytes isolated from rat fetal metatarsal growth plates. Then, we assessed cell proliferation, differentiation, and apoptosis in chondrocytes transfected with short interfering (si) RNAs specific for POR. Lastly, we studied cholesterol synthesis and Ihh protein expression in PORsiRNA transfected chondrocytes, and the effects of cholesterol and recombinant human/mouse Ihh (rIhh) on transfected chondrocytes' proliferation, differentiation, and apoptosis.
Materials and Methods

Chondrocyte culture
The cartilaginous portions of metatarsal bones isolated from Sprague Dawley rat fetuses [days post conception (dpc) 20] were diced into very small pieces (ϳ1 mm in length), rinsed in PBS, and then incubated in PBS containing 0.2% trypsin for 1 h and 0.2% collagenase in PBS for 3 h. Cell suspension was aspirated repeatedly and filtered through a 70-m nylon cell strainer (Fisher Scientific, Pittsburgh, PA), rinsed first in PBS then serum-free DMEM, and counted. Chondrocytes were seeded in 100-mm dishes at a density of 5 ϫ 10 4 /cm 2 in DMEM with 100 U/ml penicillin and 100 g/ ml streptomycin, 50 g/ ml ascorbic acid, and 10% fetal bovine serum. The culture medium was changed on d 2. Once they reached 70 -80% confluence (ϳ72 h after being placed in culture), chondrocytes were subcultured for transfection.
siRNA transfection
One day before transfection, chondrocytes were plated in 500 l of growth medium without antibiotics, such that they were 30 -50% confluent at the time of transfection. Cells were transfected with siRNAs targeted for mouse POR (POR siRNA; Santa Cruz Biotechnology, Santa Cruz, CA; catalog no. sc-35148) using LipofectAMINE 2000 (Invitrogen Corp., Carlsbad, CA). We used a pool of three target-specific, 20-to 25-nucleotide-long siRNAs designed to knock down POR gene expression. These included: sense strand (A), GAAGAGGAUUUCAUCACAUtt (mRNA location 689); sense strand (B), GAUGUCAUCAUGUCUCUAAtt (mRNA location 1079); and sense strand (C), CUGUGGACUAUGUUAAGAAtt (mRNA location 2028). As a control siRNA (Santa Cruz Biotechnology; catalog no. sc-44230), we used a siRNA consisting of a scrambled sequence of similar length. The transfected cells were cultured in DMEM containing 10% fetal calf serum for 72 h after transfection.
To determine transfection efficiency, we transfected chondrocytes isolated from rat metatarsal growth plates with fluorescein-conjugated control siRNA (Santa Cruz; catalog no. sc-36869). Transfection efficiency was determined by using a fluorescence microscope, with chondrocytes exhibiting both the green (due to fluorescein conjugated control siRNA) and blue (due to 4Ј,6-diamidino-2-phenylindole, a specific nuclear staining) colors being considered positive (transfected) cells (Supplemental Fig.1S , published as supplemental data on The Endocrine Society's Journals online web site at http://endo.endojournals.org). We calculated the number of positive cells divided by the total number of cells per grid and analyzed five grids per sample in two separate experiments (total of 10 grids) The grid circumscribed a portion of the cell sample analyzed through a ϫ10 objective and generally contained an average of 40 cells. Transfection efficiency was 45.0 Ϯ 2.4% (range 30.8 -51.4%).
To determine whether the POR siRNAs specifically silenced POR expression, we evaluated POR mRNA by real-time PCR, and protein expression by Western blot in both POR siRNA-transfected-and control siRNA-transfected chondrocytes. To optimize the effects of POR siRNAs on POR gene expression, we first tested graded concentrations of POR siRNAs (20 -80 pmol) and lipofectAMINE 2000 (1-3 l). mRNA and protein expression studies identified the 20 pmol POR siRNA in 1 l lipofectAMINE as the lowest effective concentration to silence POR mRNA and protein expression (data not shown). Thus, we used this concentration for both POR and control siRNAs in all the subsequent transfection experiments. After transfection with control siRNA or POR siRNA, cells were cultured with 100 nM cholesterol (complexed with methyl-␤-cyclodextrin; Sigma-Aldrich, St. Louis, MO; catalog no. C-4951) or the aminoterminal peptide of the human/mouse rIhh (R&D Systems, Minneapolis, MN; catalog no. 1705-HH). Because preliminary experiments with graded concentrations of cholesterol and rIhh (1-100 nM) identified 100 nM as the lowest effective concentration able to neutralize the POR siRNA-mediated effects on chondrogenesis (data not shown), we used such concentration for both compounds in all subsequent experiments regarding 3 H-thymidine incorporation, collagen X mRNA expression, in situ cell death, and caspase-3 activity.
H-thymidine incorporation
To assess cell proliferation in cultured chondrocytes, we measured 
Real-time PCR
At the end of the culture period, total RNA was extracted from cultured chondrocytes or the adrenal cortex of 4-wk-old rats using the RNeasy minikit (QIAGEN Inc., Valencia, CA). The recovered RNA was further processed using first-strand cDNA synthesis kit for RT-PCR (AMV; Roche Diagnostics Corp., Indianapolis, IN) to produce cDNA. Two micrograms of total RNA and 1.6 g of oligo-p(dT) 15 primer were incubated for 10 min at 25 C, followed by incubation for 60 min at 42 C in the presence of 20 U AMV reverse transcriptase and 50 U of RNase inhibitor in a total 20 l reaction. The cDNA products were directly used for PCR or stored at Ϫ80 C for later analysis. Real-time quantitative PCR was carried out using StepOne real-time PCR system (Applied Biosystems, Foster City, CA) in a final volume of 25 l containing 1 l cDNA, 12.5 l 2 ϫ SYBR Green master mix (Applied Biosystems), and 0.1 M primers (Applied Biosystems) in deoxyribonuclease-free water. Primers used were: rat collagen X (AJ131848) (forward), 5Ј-TCT GTA CAA CAG GCA GCA GCA CTA-3Ј, (reverse), 5Ј-GTA CAT TGT GGG CGT Endocrinology, June 2009, 150(6):2732-2739 endo.endojournals.orgGCC ATT CTT-3Ј; rat POR (NM_031576) (forward), 5Ј-GCA CTT CAA TGC CAT GGG CAA GTA-3Ј, (reverse), 5Ј-ACT GCT CCC TCC ACG TGA TGA AAT-3Ј; rat ␤-actin (NM_031144) (forward), 5Ј-TGA GCG CAA GTA CTC TGT GTG GAT-3Ј, (reverse), 5Ј-TAG AAG CAT TTG CGG TGC ACG ATG-3Ј. The PCR conditions were: 50 C for 2 min followed by 40 cycles at 95 C for 15 sec and 60 C for 1 min. Product sizes were collagen X, 148 bp; POR, 131 bp; and ␤-actin, 129 bp. Values were quantified using the comparative cycle threshold method, and samples were normalized to ß-actin.
Caspase-3 assay
Cytosolic caspase-3 activity was determined in a medium containing 50 mM Tris-HCl buffer (pH 7.0), 0.5 mM Na-EDTA, 20% glycerol, 500 g cytosolic protein, and 75 M of a synthetic fluorogenic substrate containing the recognition sequence for caspase-3 (Ac-DEVD-AMC; Millipore, Billerica, MA). The caspase-3 activity was measured spectrofluorometrically at 460 nm using 380 nm excitation wavelength at 37 C for 150 sec. The relative level of caspase-3 activity was expressed as nanomoles per milligram protein per hour. Results are expressed as percent of control siRNA-transfected cells (mean Ϯ SE) and were obtained from three separate experiments.
Western blot
At the end of the culture period, chondrocytes were solubilized with 1% sodium dodecyl sulfate sample buffer. Rat adrenal cortex was homogenized and centrifuged at 1000 ϫ g for 10 min, with the supernatant further centrifuged at 100,000 ϫ g for 60 min. Chondrocyte and adrenal lysates were electrophoresed (60 g protein/sample) on a 4 -15% SDS-PAGE gel (Bio-Rad, Richmond, CA). Proteins were transferred onto a nitrocellulose membrane and probed with the following primary antibodies: goat polyclonal antibody against Ihh mapping at the C terminus of Ihh of human origin (Santa Cruz Biotechnology; catalog no. sc-1196); mouse monoclonal antibody raised against POR of human origin (Santa Cruz Biotechnology; catalog no. sc-25270). The blots were developed using a horseradish peroxidase-conjugated polyclonal goat-antirabbit IgG antibody and enhanced chemiluminescence system (Amersham). The protein size was confirmed by molecular weight standards (Invitrogen). The intensity of the bands on Western blots was analyzed by Image J (software from National Center for Biotechnology Information, Bethesda, MD). Results are expressed as percent control siRNA-transfected cells and were obtained from three separate experiments.
In situ cell death
At the end of the culture period, chondrocytes were briefly washed with PBS and fixed in Ϫ10 C methanol for 5 min and then air dried. Apoptotic cells were identified by terminal deoxynucleotidyl transferase (TdT)-fragment end labeling, according to the manufacturer's instructions (TDT-FragEL kit; Oncogene Research Products, Boston, MA). A positive control was generated by covering the entire tissue section with 1 g/l deoxyribonuclease I in 1ϫ Tris-buffered saline/1 mM MgSO 4 for 20 min after proteinase K treatment, whereas a negative control was generated by substituting distilled water for the TdT in the reaction mixture.
Apoptosis was quantitated by determining the apoptotic index (calculated as the number of apoptotic cells per grid divided by the total number of cells per grid). The grid circumscribed a portion of chondrocytes analyzed through a ϫ40 objective and generally contained an average of 30 cells. In each slide, the apoptotic index was calculated separately in four distinct grid locations and then averaged. For each group, we sampled three slides during each experiment. Results are expressed as percent control siRNA-transfected cells and were obtained from three separate experiments. All determinations were made by the same observer blinded to the treatment category.
Cholesterol quantitation
Intracellular cholesterol level was evaluated with cholesterol/cholesteryl ester quantitation kit (BioVision Inc., Mountain View, CA). Cholesterol level was measured according to the manufacturer's instruction.
Statistics
All data are expressed as the mean Ϯ SE. Statistical significance was determined by t test or ANOVA.
Results
Expression of POR in chondrocytes
POR mRNA expression was detected in chondrocytes isolated from the cartilaginous regions of fetal (20 dpc) rat metatarsal growth plates (Fig. 1A) . Western blots from chondrocyte lysates confirmed the POR protein expression (Fig. 1B) .
Effects of POR siRNA on POR expression in chondrocytes
To demonstrate the specific inhibitory effect of POR siRNA on POR expression, we evaluated POR mRNA and protein ex- pression in cultured chondrocytes transfected with POR siRNA. POR siRNA reduced both mRNA (assessed by real time PCR, 0.61 Ϯ 0.03-fold compared with control siRNA, P Ͻ 0.01; Fig. 1C ) and POR protein expression (assessed by Western blot and densitometric analysis, 57.9 Ϯ 7.1% of control siRNA, P Ͻ 0.05; Fig. 1D ).
Effects of POR siRNA on chondrocyte proliferation and differentiation
Cultured chondrocytes isolated from the metatarsal cartilaginous regions were transfected with a control siRNA or POR siRNA. When compared with control siRNA-transfected cells, POR siRNA-transfected chondrocytes exhibited reduced chondrocyte proliferation (assessed by total 3 H-thymidine incorporation, 67.4 Ϯ 6.6% of control siRNA, P Ͻ 0.01; Fig. 2A ) and collagen X mRNA expression, a marker of chondrocyte differentiation (assessed by real time PCR, 0.69 Ϯ 0.05-fold compared with control siRNA, P Ͻ 0.05; Fig. 2B ).
Effects of POR siRNA on chondrocyte apoptosis
We first evaluated the effects of POR siRNA on chondrocyte in situ cell death. When compared with control siRNA, POR siRNA significantly induced in situ cell death in cultured chondrocytes (assessed by TdT-fragment end labeling, Fig. 3 , A and B: representative slides of control siRNA and POR siRNA transfected chondrocytes, respectively; Fig. 3C : apoptotic index, 178.1 Ϯ 13.9% of control siRNA, P Ͻ 0.01).
To determine the molecular mechanisms underlying chondrocyte apoptosis, we studied the effects of POR siRNA on caspase-3 activity. In cultured chondrocytes, POR siRNA significantly induced caspase-3 activity (243.1 Ϯ 17.4% of control siRNA, P Ͻ 0.05; Fig. 3D ).
Effects of cholesterol on POR siRNA-transfected chondrocyte proliferation, differentiation, and apoptosis
We first measured the intracellular cholesterol content in siRNA-transfected cells. POR siRNAtransfected chondrocytes exhibited a significantly lower cholesterol content when compared with control siRNA-transfected chondrocytes (81.6 Ϯ 4.4% of control siRNA, P Ͻ 0.05). We then cultured control siRNA-or POR siRNA-transfected chondrocytes with 100 nM cholesterol or equivalent concentration of methyl ␤-cyclodextrin for 24 h. The addition of cholesterol neutralized the POR siRNAmediated inhibition of chondrocyte proliferation (assessed by 3 H-thymidine incorporation, Fig. 4A and supplemental Table 1S ), differentiation (assessed by collagen X mRNA expression, Fig. 4B and supplemental Table 1S ), and the POR siRNA-mediated induction of chondrocyte apoptosis (assessed by in situ cell death and caspase-3 activity, Fig. 4 , C and D, respectively, and supplemental Table 1S ).
Effects of rIhh on POR siRNA-transfected chondrocyte proliferation, differentiation, and apoptosis
To determine the molecular mechanisms underlying the effects of POR on chondrogenesis, we evaluated Ihh protein expression in POR siRNA-transfected chondrocytes and cultured without or with 100 nM cholesterol. When compared with control siRNA-transfected chondrocytes, POR siRNAtransfected chondrocytes exhibited decreased Ihh ex- We then studied the effects of rIhh on POR siRNA-transfected chondrocyte proliferation, differentiation, and apoptosis. The addition of 100 nM rIhh in the culture medium for 24 h neutralized the POR siRNA-mediated reduced 3 H-thymidine incorporation ( Fig. 6A and supplemental Table 2S ) and collagen X mRNA expression (Fig. 6B and supplemental Table 2S ) and increased apoptotic index (Fig. 6C and supplemental Table 2S ) and caspase-3 activity (Fig. 6D and supplemental Table 2S ).
Discussion
In recent years, experimental evidence in mice and the description of a genetic disorder in humans have shed light on the role of POR in skeletal physiology. Targeted deletion of microsomal POR expression in mice leads to embryonic lethality, with a variety of embryonic defects detectable by d 10.5 of gestation (10, 11) . In the mutated embryos, fore and hind limb formation, as well as cranial development, is delayed.
After the initial description of a patient with ambiguous genitalia and abnormal steroidogenesis (24) subsequently suspected to be due to POR deficiency (25) , the majority of patients thus far identified with POR mutations also exhibit bone abnormalities characteristic of Antley-Bixler syndrome (3, (13) (14) (15) (16) (17) (18) . Unlike patients with POR mutations, patients with Antley-Bixler and no abnormality of the steroidogenic pathway/genital development harbor a gainof-function mutation of the fibroblast growth factor receptor 2 (26 -30) . Whereas the role of fibroblast growth factors and their receptors in skeletal development and growth has been well described, little is known on the underlying mechanisms of skeletal malformations in patients with POR mutations. It has been hypothesized that a defective cholesterol synthesis may be implicated in the abnormal skeletal development associated with impaired POR activity (10, 12, 17) . Several lines of evidence support this hypothesis: 1) two enzymes participating to cholesterol biosynthesis (lanosterol-14␣-demethylase and squalene monooxygenase) require POR as electron donor (21, 22) ; 2) a patient with Antley-Bixler syndrome, ambiguous genitalia, and a POR mutation has been reported with increased lanosterol and dihydrolanosterol, consistent with an impaired activity of lanosterol-14␣-demethylase but a normal lanosterol-14␣-demethylase gene (31); 3) previous reports have also associated features of Antley-Bixler syndrome in offspring of mothers who ingested fluconazole, an antifungal medication that inhibits yeast lanosterol-14␣-demethylase (32, 33); 4) a number of inborn errors of cholesterol biosynthesis (20) , such as Smith-Lemli-Opitz syndrome, x-linked dominant chondrodysplasia punctata, and congenital hemidysplasia with ichthyosiform erythema and limb defects, all exhibit variable degrees of abnormal skeletal development. In addition, we previously demonstrated that the targeted inhibition of cholesterol synthesis in cultured metatarsal bones (through the activity of an inhibitor of 7-dehydrocholesterol reductase) results in suppressed longitudinal bone growth, chondrocyte proliferation, and chondrocyte hypertrophy (21) .
In our study, the targeted silencing of POR in growth plate chondrocytes led to decreased chondrocyte proliferation and dif- 
FIG. 5.
Effects of POR siRNA and cholesterol on Ihh protein expression. Chondrocytes were transfected with a control siRNA or POR siRNA. After transfection, chondrocytes were cultured without or with 100 nM cholesterol for 24 h. At the end of the culture period, they were harvested, lysed, electrophoresed, and immunoblotted for Ihh and the loading control, ␤-actin. A representative blot from three independent experiments is presented. ferentiation and increased apoptosis. In addition, POR siRNAtransfected chondrocytes were found with a reduced cholesterol content. More importantly, the addition of cholesterol in the culture medium of these transfected chondrocytes neutralized their reduced cell proliferation and differentiation and induced apoptosis. These findings indicate that suppressed chondrogenesis secondary to silenced POR expression in chondrocytes depends on reduced cholesterol synthesis.
On the other hand, the skeletal phenotype associated with inborn errors of cholesterol synthesis is not identical in all of these genetic disorders. For instance, individuals may exhibit craniosynostosis (Antley-Bixler syndrome and POR mutations) or microcephaly without craniosynostosis (Smith-Lemli-Opitz syndrome), or no cranial abnormalities (congenital hemidysplasia with ichthyosiform erythema and limb defects syndrome). Furthermore, severe POR mutations cause skeletal malformations, whereas mild POR mutations are associated with normal skeletal development (13) . Such differences may be due to a variable degree of cholesterol deficiency in the skeletal sites involved or the specific sterol profile secondary to the impaired enzymatic activity characterizing each of these genetic defects (20) . Lastly, our findings related to reduced expression of POR or synthesis of cholesterol in growth plate chondrocytes may explain only some of the skeletal features characterizing Antley-Bixler syndrome and many inborn error of cholesterol biosynthesis. Specifically, impaired growth plate function results in abnormalities of the bones formed by endochondral ossification (i.e. long bones of the limbs) but not of those formed by intramembranous ossification (cranial bones).
To determine the molecular mechanisms by which reduced cholesterol synthesis leads to impaired chondrogenesis, we evaluated the protein expression of Ihh in POR siRNA-transfected chondrocytes. Ihh, along with Sonic hedgehog and Desert hedgehog, belongs to a family of transcription factors regulating embryonic patterning, limb development, and growth plate chondrogenesis (34) . Ihh is localized in the growth plate (35) in which it modulates chondrocyte proliferation and differentiation/ hypertrophy (34) . Indeed, the selective ablation of Ihh in mouse chondrocytes results in decreased chondrocyte proliferation and delayed chondrocyte differentiation/hypertrophy (36) .
Cholesterol has been shown to be necessary for the activity of members of the hedgehog (Hh) family (37) . After being synthesized intracellularly, the Nterminal half of Hh proteins becomes conjugated with cholesterol by an autocatalytic reaction that simultaneously cleaves off the inactive C-terminal polypeptide (38) . The mature active Hh protein, which is about half the size of full-length Hh, can then be anchored to the cell membrane and eventually released from the secreting cell. Here we show that POR siRNA-transfected chondrocytes exhibit a reduced Ihh expression, with the addition of cholesterol in the culture medium preventing such POR siRNA-mediated effect. Such a finding is consistent with the reduced Ihh expression previously observed by us in the growth plate of rat metatarsal bones cultured in the presence of AY 9944, an inhibitor of cholesterol synthesis (21) . The functional importance of Ihh in mediating the POR/cholesterol effects on chondrogenesis is supported by the rIhh-mediated reversal of reduced cell proliferation and differentiation and induced apoptosis in POR siRNA-transfected chondrocytes. Although this is the first evidence suggesting a regulatory role for Ihh on chondrocyte apoptosis, previous evidence indicates that inhibition of the hedgehog pathway causes a massive induction of cell apoptosis in hepatoblastoma and the fetal rat testis (39, 40) . Similar to our findings, the induced apoptosis resulting from the prevention of hedgehog activity appears to be mediated by caspase-3 (39, 40) .
It has been speculated that the skeletal abnormalities described in patients with POR mutations might be due to retinoic acid excess or deficiency (11) because POR functions as an electron donor for CYP26A1, a hepatic enzyme involved in retinoic acid metabolism. Retinoic acid excess as well as deficiency in pregnant animals has teratogenic effects affecting the skeleton (41) . In addition, we have previously shown that retinoic acid inhibits longitudinal growth of cultured rat metatarsal bones by suppressing chondrocyte proliferation, hypertrophy, and matrix synthesis (42) . On the other hand, the most typical features of CYP26A1 knockout mice, caudal truncations and vertebral malformations, are not seen in Por knockout mice (43, 44) . Furthermore, liver-specific knockout of Por results in morphologi-cally normal mice (45) , suggesting that the skeletal abnormalities of Por knockout mice (and, possibly, of patients with POR mutations) do not depend from the decreased activity of a hepatic enzyme such as CYP26A1.
In conclusion, our study indicates that the normal activity of POR has facilitatory effects on the autocrine/paracrine regulation of growth plate chondrogenesis and bone growth. Thus, our findings suggest that the bone abnormalities associated with POR mutations result from the impaired expression of POR in chondrocytes. Such impaired expression leads to reduced cholesterol synthesis; decreased Ihh expression/activity; and, in turn, suppressed chondrogenesis.
